henhaobio
Sign in

Abstract

Cytoplasmic TDP43 mislocalization and aggregation are pathological hallmarks of amyotrophic lateral sclerosis (ALS). However, the initial cellular insults that lead to TDP43 mislocalization remain unclear. In this study, we demonstrate that Nemo-like kinase (NLK)--a proline-directed serine/threonine kinase--promotes the mislocalization of TDP43 and other RNA-binding proteins by disrupting nuclear import. NLK levels are selectively elevated in neurons exhibiting TDP43 mislocalization in ALS patient tissues, while genetic reduction of NLK reduces toxicity in human neuron models of ALS. Our findings suggest that NLK is a promising therapeutic target for neurodegenerative diseases.

Citations
2
FWCI
1.22
Field percentile
top 22%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISTejwani '23Zhang '24Dalton '25Hao '21Plessis‐Bel '24Dyer '20
82% semantic matchNeuroscience
Leon Tejwani, Youngseob Jung, Hiroshi Kokubu+17 more·Journal of Clinical Investigation·Jun 29, 2023· 17 citations